Famotidine and Perforomist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Famotidine (famotidine) and Perforomist (formoterol fumarate). Common drug interactions include pseudomonas infection among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Famotidine and Perforomist. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,421 Famotidine users. Check the latest studies of Famotidine.

What is Perforomist?

Perforomist has active ingredients of formoterol fumarate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 1,431 Perforomist users. Check the latest studies of Perforomist.



On Jul, 12, 2026

39 people who take Famotidine and Perforomist together, and have interactions are studied.

Famotidine and Perforomist drug interactions.

What are the common drug interactions of Famotidine and Perforomist, by gender? *:

female:

  1. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  2. Pyrexia (fever)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Stomach mass
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Swelling
  8. Sinusitis (inflammation of sinus)
  9. Headache (pain in head)
  10. Fatigue (feeling of tiredness)

male:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Localised infection (infection at the single location)
  3. Constipation
  4. Cough
  5. Diarrhoea
  6. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Feeling jittery
  9. Headache (pain in head)
  10. Hypokalaemia (low potassium)

What are the common drug interactions of Famotidine and Perforomist, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pneumonia
  2. Adverse drug reaction
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  5. Fatigue (feeling of tiredness)
  6. Infusion site bruising
  7. Infusion site pain
  8. Post procedural discharge
  9. Sinusitis (inflammation of sinus)
  10. Constipation

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Tinnitus (a ringing in the ears)
  4. Vomiting
  5. Pneumonia
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Fatigue (feeling of tiredness)
  10. Feeling hot

60+:

  1. Sinusitis (inflammation of sinus)
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Paranasal sinus hypersecretion
  4. Respiratory tract infection
  5. Seasonal allergy (allergic condition due to certain season)
  6. Anxiety
  7. Cataract (clouding of the lens inside the eye)
  8. Depression
  9. Ear pain
  10. Gastric cancer (stomach cancer)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 15 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and Perforomist?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Famotidine and Perforomist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Perforomist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Famotidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perforomist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and formoterol fumarate (the active ingredients of Famotidine and Perforomist, respectively), and Famotidine and Perforomist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: